Answers are grounded in this paper and cite their sources.
Potent antiproliferative activity against diverse breast cancer subtypes was achieved with novel N -(4,5,6,7-tetrahydrobenzo[ d ]isoxazol-5-yl)carboxamides that modulate HSP90 and inhibit oncogenic kinases.
No takes yet. Share an insight, caveat, or question.
Varabyeva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: